on 24 Jan 2025
Last Applicant/ Owned by
Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm
SE
Serial Number
2167461 filed on 1st Feb 2022
Registration Number
TMA1285999 registered on 24th Jan 2025
Registration expiry Date
16th May 2034Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO
ONTARIO
CA
M5X1G5
Trademark usage description
medical and pharmaceutical preparations for the treatment of blood disorders, cancer, immunologic diseases, namely, autoimmune diseases and immunologi Read More10
10
10
10
2167461
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 8th Jun 2023 | Search Recorded |
Submitted for opposition 20 on 8th Jun 2023 | Examiner's First Report |
Submitted for opposition 223 on 8th Jun 2023 | Total Provisional Refusal |
Submitted for opposition 256 on 19th Dec 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 18th Mar 2022 | Agent Changed |
Submitted for opposition 257 on 17th Feb 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 17th Feb 2022 | Created |
Submitted for opposition 31 on 17th Feb 2022 | Formalized |
Submitted for opposition 30 on 1st Feb 2022 | Filed |
Submitted for opposition 228 on 16th May 2014 | International Registration |